Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions

by dyadic | Feb 21, 2024 | Press Releases

JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a global biotechnology company specializing in advanced microbial platforms for protein...

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

by dyadic | Feb 13, 2024 | Press Releases

JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) — Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences® (Nasdaq: MRVI), announced today a...

Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company

by dyadic | Feb 6, 2024 | Press Releases

JUPITER, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company announced it has signed a fully...

Dyadic to Attend BIO CEO & Investor Conference and European Industry Events

by dyadic | Feb 1, 2024 | Press Releases

JUPITER, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for...

Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference

by dyadic | Jan 2, 2024 | Press Releases

JUPITER, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for...